Healthcare - Biotechnology - NASDAQ - US
$ 5.8
-3.65 %
$ 328 M
Market Cap
-6.82
P/E
INCOME STATEMENT
0
REVENUE
-78.2 M
OPERATING INCOME
-66.9 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Design Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 537 K |
| Gross Profit | -537 K |
| Operating Expenses | 78.2 M |
| Operating Income | -78.2 M |
| Other Expenses | -11.3 M |
| Net Income | -66.9 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 226 | 834 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0.5 | 0.5 | 0.1 | 5 K | 1.65 K |
| Gross Profit | (0.5) | (0.5) | (0.1) | 4.77 K | 820 |
| OPERATING INCOME | |||||
| Operating Expenses | 78.2 | 67.6 | 35.8 | 8.3 | 1.9 |
| Selling, General and Administrative Expenses | 21.1 | 19.0 | 11.1 | 2.5 | 1.1 |
| Research and Development Expenses | 57.1 | 48.6 | 24.8 | 6.1 | 1.7 |
| Operating Income | (78.2) | (67.6) | (35.8) | (8.3) | (1.9) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | (4.7) | 0 | 0 | 0 |
| Total Other Income | 11.3 | 4.3 | 0.3 | 50 K | (0.1) |
| Pre-Tax Income | (66.9) | (63.3) | (35.5) | (8.3) | (2.0) |
| NET INCOME | |||||
| Tax Provision | 1 | (4.7) | (0.1) | (0.2) | 1.91 K |
| Net Income | (66.9) | (58.6) | (35.5) | (8.3) | (2.0) |
| EPS | 1.19 | 1.05 | 0.77 | 0.3 | 0.0753 |